SIAH2
SIAH2 (siah E3 ubiquitin protein ligase 2) is a RING-type E3 ubiquitin ligase of the SINA (seven in absentia) family. It mediates ubiquitination and proteasomal degradation of specific substrates and has been implicated in the cellular response to hypoxia. Browse Assay Genie's current range of SIAH2 research reagents below, or read on for the biology behind the target.
SIAH2 is an E3 ubiquitin-protein ligase that targets proteins for ubiquitination and subsequent proteasomal degradation. Like other E3 ligases, it accepts ubiquitin from an E2 ubiquitin-conjugating enzyme as a thioester and transfers it directly to the substrate. It can act through direct binding to substrates or as the essential RING domain subunit of larger E3 complexes.
Reported substrates include the transcription regulators GPS2, POU2AF1, PML and NCOR1, the cell surface receptor DCC, the antiapoptotic protein BAG1 and the synaptic vesicle protein SYP. SIAH2 mediates degradation of DYRK2 in response to hypoxia, and of EGLN2 and EGLN3 during the unfolded protein response, which leads to stabilisation of ATF4. It also promotes monoubiquitination of SNCA and, in the Wnt signalling pathway, mediates Wnt-induced degradation of AXIN1. Through these activities it is involved in apoptosis, tumour suppression, the cell cycle, transcription and signalling.
SIAH2 also regulates the circadian clock by ubiquitinating the transcriptional repressors NR1D1 and NR1D2, contributing to the rhythmic profile of their abundance. It has some overlapping function with SIAH1, but triggers degradation of TRAF2, which SIAH1 does not. The SIAH2 protein is found in the cytoplasm and nucleus and belongs to the SINA family, and the human gene is classed with the RING finger E3 ubiquitin protein ligases. The name derives from the Drosophila seven in absentia gene, and the mouse and rat orthologs are also named Siah2.
SIAH2 activity has been implicated in the cellular response to hypoxia, including degradation of DYRK2 and the EGLN prolyl hydroxylases EGLN2 and EGLN3.
SIAH2 ubiquitinates NR1D1 and NR1D2, driving their rhythmic proteasomal clearance and shaping their circadian protein abundance.
SIAH2 mediates Wnt-induced proteasomal degradation of AXIN1 and degrades TRAF2, linking ubiquitination to signalling control.
By degrading substrates such as BAG1 and PML, SIAH2 is involved in apoptosis, cell cycle control and tumour suppression.
SIAH2 is an E3 ubiquitin ligase that mediates ubiquitination and proteasomal degradation of target proteins. Substrates include NCOR1, PML, BAG1, DCC, TRAF2, NR1D1, NR1D2 and AXIN1, so it contributes to apoptosis, the cell cycle, transcription, circadian regulation and signalling.
The HGNC name is siah E3 ubiquitin protein ligase 2, and UniProt lists E3 ubiquitin-protein ligase SIAH2. Earlier names were seven in absentia homolog 2 (Drosophila), reflecting the Drosophila seven in absentia gene. No alternative gene symbols are recorded.
SIAH2 and SIAH1 belong to the SINA family and partly overlap in function, but SIAH2 triggers TRAF2 degradation whereas SIAH1 does not. The mouse and rat orthologs are both called Siah2; check the datasheet of any product for its validated reactivity.
Other SINA family ligases, SIAH2 substrates and hypoxia, circadian and Wnt pathway proteins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O43255; product specifications from Assay Genie datasheets.